Details for New Drug Application (NDA): 022048
✉ Email this page to a colleague
The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 022048
Tradename: | TRIESENCE |
Applicant: | Harrow Eye |
Ingredient: | triamcinolone acetonide |
Patents: | 2 |
Pharmacology for NDA: 022048
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 022048
Suppliers and Packaging for NDA: 022048
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048 | NDA | Novartis Pharmaceuticals Corporation | 0078-0897 | 0078-0897-78 | 1 BLISTER PACK in 1 CARTON (0078-0897-78) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS |
TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048 | NDA | Harrow Eye, LLC | 82667-800 | 82667-800-01 | 1 BLISTER PACK in 1 CARTON (82667-800-01) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAVITREAL | Strength | 40MG/ML (40MG/ML) | ||||
Approval Date: | Nov 29, 2007 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Dec 17, 2029 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 10, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF OPHTHALMIC DISORDERS | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Mar 10, 2029 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | VISUALIZATION DURING VITRECTOMY PROCEDURES |
Expired US Patents for NDA 022048
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Harrow Eye | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription